Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — April 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 6, 2026
Sale
Shares
1,205
Price
$556.06
Total Value
$670.05K
Shares Held After
25,956
% of Holdings
4.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 6, 2026
Sale
Shares
1,158
Price
$555.21
Total Value
$642.94K
Shares Held After
27,161
% of Holdings
4.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 6, 2026
Sale
Shares
437
Price
$553.97
Total Value
$242.08K
Shares Held After
28,319
% of Holdings
1.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 6, 2026
Sale
Shares
120
Price
$552.78
Total Value
$66.33K
Shares Held After
28,756
% of Holdings
0.4%
Apr 6, 2026
Purchase
Shares
5,000
Price
$6.32
Total Value
$31.60K
Shares Held After
3,017,000
% of Holdings
0.2%

Alkermes plc. (ALKS)

Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Apr 6, 2026
Sale
Shares
2,034
Price
$34.57
Total Value
$70.32K
Shares Held After
233,592
% of Holdings
0.9%

Lipocine Inc. (LPCN)

Higuchi John W. — Director
Apr 6, 2026
Purchase
Shares
123,000
Price
$2.05
Total Value
$252.15K
Shares Held After
163,797
% of Holdings
75.1%

BICYCLE THERAPEUTICS PLC (BCYC)

Thompson Travis Alvin — Chief Financial Officer
Apr 6, 2026
Sale
Shares
102
Price
$5.05
Total Value
$515.10
Shares Held After
65,364
% of Holdings
0.2%
Apr 6, 2026
Sale
Shares
6,775
Price
$18.50
Total Value
$125.34K
Shares Held After
4,555,741
% of Holdings
0.1%
Apr 6, 2026
Sale
Shares
44,728
Price
$17.31
Total Value
$774.24K
Shares Held After
4,562,516
% of Holdings
1.0%
Apr 6, 2026
Sale
Shares
537,754
Price
$16.51
Total Value
$8.88M
Shares Held After
4,607,244
% of Holdings
10.5%
Apr 6, 2026
Sale
Shares
1,716
Price
$5.05
Total Value
$8.67K
Shares Held After
611,313
% of Holdings
0.3%

Lipocine Inc. (LPCN)

Patel Mahesh V. — Director
Apr 6, 2026
Purchase
Shares
25,000
Price
$2.03
Total Value
$50.75K
Shares Held After
160,679
% of Holdings
15.6%

BICYCLE THERAPEUTICS PLC (BCYC)

Skynner Michael — CHIEF SCIENTIFIC OFFICER
Apr 6, 2026
Sale
Shares
525
Price
$5.05
Total Value
$2.65K
Shares Held After
159,562
% of Holdings
0.3%

BICYCLE THERAPEUTICS PLC (BCYC)

Perry Jennifer Scott — Chief Operating Officer
Apr 6, 2026
Sale
Shares
333
Price
$5.04
Total Value
$1.68K
Shares Held After
92,464
% of Holdings
0.4%

BICYCLE THERAPEUTICS PLC (BCYC)

Perry Jennifer Scott — Chief Operating Officer
Apr 6, 2026
Sale
Shares
37
Price
$5.05
Total Value
$186.85
Shares Held After
92,797
% of Holdings
0.0%

BICYCLE THERAPEUTICS PLC (BCYC)

Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Apr 6, 2026
Sale
Shares
251
Price
$5.05
Total Value
$1.27K
Shares Held After
96,136
% of Holdings
0.3%

Contineum Therapeutics, Inc. (CTNM)

Lorrain Daniel S. — Chief Scientific Officer
Apr 6, 2026
Sale
Shares
4,170
Price
$13.43
Total Value
$56.01K
Shares Held After
147,712
% of Holdings
2.7%

Altimmune, Inc. (ALT)

GILL JOHN — Director
Apr 6, 2026
Purchase
Shares
9,200
Price
$3.41
Total Value
$31.35K
Shares Held After
21,700
% of Holdings
42.4%

MESOBLAST LTD (MESO)

George Gregory — Director
Apr 4, 2026
Purchase
Shares
4,000,000
Price
$1.42
Total Value
$5.68M
Shares Held After
12,000,000
% of Holdings
33.3%

MESOBLAST LTD (MESO)

George Gregory — Director
Apr 4, 2026
Purchase
Shares
4,000,000
Price
$1.42
Total Value
$5.68M
Shares Held After
12,000,000
% of Holdings
33.3%
Apr 2, 2026
Sale
Shares
1,134
Price
$34.80
Total Value
$39.46K
Shares Held After
144,974
% of Holdings
0.8%
Apr 2, 2026
Sale
Shares
374
Price
$33.35
Total Value
$12.47K
Shares Held After
144,974
% of Holdings
0.3%
Apr 2, 2026
Sale
Shares
1,794
Price
$32.60
Total Value
$58.49K
Shares Held After
144,974
% of Holdings
1.2%
Apr 2, 2026
Sale
Shares
1,265
Price
$31.75
Total Value
$40.17K
Shares Held After
144,974
% of Holdings
0.9%
Apr 2, 2026
Sale
Shares
3,099
Price
$30.86
Total Value
$95.65K
Shares Held After
144,974
% of Holdings
2.1%
Apr 2, 2026
Purchase
Shares
701
Price
$35.55
Total Value
$24.92K
Shares Held After
144,974
% of Holdings
0.5%
Apr 2, 2026
Purchase
Shares
1,276
Price
$34.75
Total Value
$44.34K
Shares Held After
144,974
% of Holdings
0.9%
Apr 2, 2026
Purchase
Shares
26
Price
$33.47
Total Value
$870.23
Shares Held After
144,974
% of Holdings
0.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
8
Price
$325.49
Total Value
$2.60K
Shares Held After
11,729
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
81
Price
$323.64
Total Value
$26.21K
Shares Held After
11,737
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
245
Price
$322.86
Total Value
$79.10K
Shares Held After
11,818
% of Holdings
2.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
224
Price
$321.64
Total Value
$72.05K
Shares Held After
12,063
% of Holdings
1.8%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
147
Price
$320.62
Total Value
$47.13K
Shares Held After
12,287
% of Holdings
1.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
86
Price
$319.69
Total Value
$27.49K
Shares Held After
12,434
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
209
Price
$318.47
Total Value
$66.56K
Shares Held After
12,520
% of Holdings
1.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
359
Price
$317.44
Total Value
$113.96K
Shares Held After
12,729
% of Holdings
2.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

McLaughlin Melissa — Chief Human Resources Officer
Apr 2, 2026
Sale
Shares
265
Price
$316.61
Total Value
$83.90K
Shares Held After
13,088
% of Holdings
2.0%
Apr 2, 2026
Purchase
Shares
20,000
Price
$6.09
Total Value
$121.80K
Shares Held After
3,012,000
% of Holdings
0.7%

BICYCLE THERAPEUTICS PLC (BCYC)

Thompson Travis Alvin — Chief Financial Officer
Apr 2, 2026
Sale
Shares
799
Price
$4.91
Total Value
$3.92K
Shares Held After
65,466
% of Holdings
1.2%
Apr 2, 2026
Sale
Shares
1,525
Price
$19.06
Total Value
$29.07K
Shares Held After
5,144,998
% of Holdings
0.0%
Apr 2, 2026
Sale
Shares
258,475
Price
$18.23
Total Value
$4.71M
Shares Held After
5,146,523
% of Holdings
4.8%
Apr 2, 2026
Sale
Shares
5,967
Price
$4.91
Total Value
$29.30K
Shares Held After
613,029
% of Holdings
1.0%

BICYCLE THERAPEUTICS PLC (BCYC)

Skynner Michael — CHIEF SCIENTIFIC OFFICER
Apr 2, 2026
Sale
Shares
1,879
Price
$4.91
Total Value
$9.23K
Shares Held After
160,087
% of Holdings
1.2%

BICYCLE THERAPEUTICS PLC (BCYC)

Perry Jennifer Scott — Chief Operating Officer
Apr 2, 2026
Sale
Shares
1,038
Price
$4.91
Total Value
$5.10K
Shares Held After
92,834
% of Holdings
1.1%

BICYCLE THERAPEUTICS PLC (BCYC)

Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Apr 2, 2026
Sale
Shares
1,521
Price
$4.91
Total Value
$7.47K
Shares Held After
96,387
% of Holdings
1.6%
Apr 2, 2026
Sale
Shares
371
Price
$21.36
Total Value
$7.93K
Shares Held After
15,150
% of Holdings
2.4%
Apr 2, 2026
Sale
Shares
415
Price
$20.52
Total Value
$8.51K
Shares Held After
15,521
% of Holdings
2.6%
Apr 2, 2026
Sale
Shares
265
Price
$21.36
Total Value
$5.66K
Shares Held After
82,027
% of Holdings
0.3%
Apr 2, 2026
Sale
Shares
293
Price
$20.51
Total Value
$6.01K
Shares Held After
82,292
% of Holdings
0.4%
Version: v26.5.2